Trial intelligence / Profile preview

Lot-to-lot Consistency of Hib-MenAC Mixed With Tritanrix-HBV in Infants

NCT00317161Phase 3Completed

Sponsor
GSK
Start
Aug 2004
Primary completion
Apr 2005
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Hib + MenAC in Haemophilus influenzae type b infection (Hib), meningococcal meningitis, sponsored by GSK. Started Aug 2004; status: completed.

02

Drugs

Hib + MenAC
03

Conditions

Haemophilus influenzae type b infection (Hib)meningococcal meningitis

Beyond the preview

Go deeper on NCT00317161.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00317161.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call